Adlai Nortye Ltd. American Depositary Shares (ANL)
Adlai Nortye Ltd. American Depositary Shares
XNAS:ANL
1.59
$1.72 - 100.00
$1.20 - 200.00
$1.37
$1.55
$1.38
$1.37
2.99
1.1
16227
11176.7
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 389
0
Chart
TendieTensor AI Analysis
Company
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Fundamentals
123
2.302210
100
BBG01HP11SV4
BBG01HP11TP9
31.24M
36.90M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ANL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.